Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06397573 · ClinicalTrials.gov registry record · NA
Ablative Stereotactic MR-Guided Adaptive Reirradiation
A NA study of Abdominal Cancer and Pelvic Cancer, sponsored by Baptist Health South Florida.
- Active
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06397573: Active NA study of Abdominal Cancer and Pelvic Cancer, sponsored by Baptist Health South Florida.
NCT06397573 is a NA study of Abdominal Cancer and Pelvic Cancer that is active but no longer recruiting, run by Baptist Health South Florida. The registered enrollment target is 10 participants, below the 87-participant average among 7 other Abdominal Cancer trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06397573, a NA study of Abdominal Cancer and Pelvic Cancer, is active but no longer recruiting, sponsored by Baptist Health South Florida.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study will enroll people who have cancer in their abdomen or pelvis that was treated previously with radiation therapy. The purpose of this research study is to test the safety and possible harms of treating tumors in these regions with another round of radiation therapy, called reirradiation or "reRT." The researchers want to find out what effects (good and bad) reRT has in people with cancer in the abdomen and pelvis.
Primary Outcome
Number of participants who experience Grade 3 or higher acute toxicity \[graded per Common Terminology Criteria for Adverse Events (CTCAE)\] possibly, probably, or definitely related to reRT.
Conditions Studied
Interventions
- RADIATION Reirradiation
Study Locations (1)
Florida
- Miami Cancer Institute at Baptist Health South Florida - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-06-05 |
| Est. Completion | 2027-06 |
| Phase | NA |
What the registry record for NCT06397573 still lists
NCT06397573 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 87-participant average among 7 other Abdominal Cancer trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Abdominal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Reirradiation is the first listed.
NCT06397573 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06397573 about?
NCT06397573 is a clinical study titled "Ablative Stereotactic MR-Guided Adaptive Reirradiation". This research study will enroll people who have cancer in their abdomen or pelvis that was treated previously with radiation therapy. The purpose of this research study is to test the safety and possible harms of treating tumors in these regions with another round of radiation therapy, called reirra...
What is the current status of trial NCT06397573?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-06-05. Estimated completion is 2027-06.
What conditions does trial NCT06397573 study?
This clinical trial studies the following conditions: Abdominal Cancer, Pelvic Cancer.
What interventions are being tested in trial NCT06397573?
The interventions under investigation include: Reirradiation (RADIATION).
Who is sponsoring clinical trial NCT06397573?
This trial is sponsored by Baptist Health South Florida, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06397573 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abdominal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Prospective Imaging Study of the Integrated TrueBeam-HyperSight CBCT System
ACTIVE NOT RECRUITING · NA
-
NSS-2 BRIDGE Device in Post-Operative Pain Management
COMPLETED · NA
-
VisionRT-based Deep Inspiration Breath-hold (DIBH) Respiratory Motion Management Strategy, A Pilot Study for Thoracic and Abdominal Tumors
COMPLETED · NA
-
Heated Versus Aerosol-based Laparoscopic Chemotherapy for Cancer That Has Spread to the Peritoneum (Abdominal Lining)
RECRUITING · Phase 2
-
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
RECRUITING
-
Feasibility Study of Intra-Tumoral Lipopolysaccharide Immunotherapy for Intra-Abdominal
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI